Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
Alternative investment firm
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Highbridge Capital Management's primary sector concentration for investments?
- Highbridge Capital Management's investments are concentrated in the Health Tech & Life Sciences sector, with both of its recorded portfolio companies falling into this category.
- When did Highbridge Capital Management make its first recorded investment?
- Highbridge Capital Management made its first recorded investment in May 2024.
- Which companies are notable in Highbridge Capital Management's portfolio?
- Highbridge Capital Management's notable portfolio companies include BiolineRx and Gamida Cell. For a full portfolio, users should refer to startupim.
- What was Highbridge Capital Management's most recent investment activity?
- Highbridge Capital Management's most recent investment activity was in November 2024, with an investment in BiolineRx.
- Has Highbridge Capital Management led any investment rounds?
- Yes, Highbridge Capital Management led an investment round for BiolineRx in November 2024, amounting to $9,000,000.
- What is the investment range for Highbridge Capital Management?
- Highbridge Capital Management's investment range is between $9 million and $30 million, based on its recorded investments.
- What types of funding stages has Highbridge Capital Management participated in?
- Highbridge Capital Management has participated in Debt Financing and PIPE funding stages.
- Has Highbridge Capital Management had any acquisitions of its portfolio companies?
- According to startupim data, Highbridge Capital Management had an acquisition in March 2024, but the company name is not specified.